Alkem Laboratories rises on getting EIR for St Louis facility

14 May 2020 Evaluate

Alkem Laboratories is currently trading at Rs. 2518.50, up by 29.80 points or 1.20% from its previous closing of Rs. 2488.70 on the BSE.

The scrip opened at Rs. 2498.00 and has touched a high and low of Rs. 2525.20 and Rs. 2478.00 respectively. So far 324 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2882.10 on 09-Apr-2020 and a 52 week low of Rs. 1660.35 on 28-Jun-2019.

Last one week high and low of the scrip stood at Rs. 2620.05 and Rs. 2468.75 respectively. The current market cap of the company is Rs. 29756.14 crore.

The promoters holding in the company stood at 66.04%, while Institutions and Non-Institutions held 14.72% and 19.24% respectively.

Alkem Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA), for its St Louis facility, USA. The inspection has been closed by the USFDA.

Earlier, the inspection was conducted by the USFDA from January 27, 2020 to February 6, 2020. At the end of the inspection, the company had received Form 483 with three observations.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5627.40 -33.30 (-0.59%)
17-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.10
Dr. Reddys Lab 1272.00
Cipla 1496.95
Zydus Lifesciences 918.35
Lupin 2113.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×